UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000036422
Receipt number R000041501
Scientific Title Clinical application of corneal endothelial regenerative medicine by means of cultured human corneal endothelial cell transplantation: long-term follow up
Date of disclosure of the study information 2019/04/05
Last modified on 2019/04/05 21:32:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical application of corneal endothelial regenerative medicine by means of cultured human corneal endothelial cell transplantation: long-term follow up

Acronym

Clinical application of corneal endothelial regenerative medicine by means of cultured human corneal endothelial cell transplantation: long-term follow up

Scientific Title

Clinical application of corneal endothelial regenerative medicine by means of cultured human corneal endothelial cell transplantation: long-term follow up

Scientific Title:Acronym

Clinical application of corneal endothelial regenerative medicine by means of cultured human corneal endothelial cell transplantation: long-term follow up

Region

Japan


Condition

Condition

Bullous Keratopathy

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To verify the long-term efficacy and safety of cultured human corneal endothelial cell transplantation.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Corneal endothelial cell density

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >

Gender

Male and Female

Key inclusion criteria

1. The patient who underwent cultured human corneal endothelial transplantation
2. Obtained informed consent to participate this study

Key exclusion criteria

The patient who was judged as inappropriate

Target sample size

45


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Kinoshita

Organization

Kyoto Prefectural University of Medicine

Division name

Frontier Medical Science and Technology for Ophthalmology

Zip code

6028566

Address

465 Kajii-cho, kamigyo-ku, Kyoto-shi, Kyoto

TEL

075-251-5772

Email

shigeruk@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Kojiro
Middle name
Last name Imai

Organization

Kyoto Prefectural University of Medicine

Division name

Department for Medical Innovation and Translational Medical Science

Zip code

6028566

Address

465 Kajii-cho, kamigyo-ku, Kyoto-shi, Kyoto

TEL

075-251-5308

Homepage URL


Email

chcec@koto.kpu-m.ac.jp


Sponsor or person

Institute

Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

KPUM IRB

Address

465 Kajii-cho, kamigyo-ku, Kyoto-shi, Kyoto

Tel

075-251-5337

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 04 Month 05 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2018 Year 10 Month 31 Day

Date of IRB

2019 Year 03 Month 12 Day

Anticipated trial start date

2019 Year 04 Month 08 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Main observations: corneal endothelial cell density and safety data


Management information

Registered date

2019 Year 04 Month 05 Day

Last modified on

2019 Year 04 Month 05 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041501


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name